Lucky Sekhon, M.D.

New York, New York, United States Contact Info
355 followers 267 connections

Join to view profile

About

Dr. Lucky Sekhon is a reproductive endocrinologist and infertility specialist and board…

Activity

Join now to see all activity

Experience & Education

  • Reproductive Medicine Associates of New York

View Lucky’s full experience

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

Licenses & Certifications

  • Board Certification in Reproductive Endocrinology and Infertility

    -

    Issued
  • New York State Medical License  Graphic

    New York State Medical License

    New York State

    Issued

Publications

  • Supraphysiologic Levels of Steroid Hormones During Frozen Embryo Transfer Cycles are not Associated with Ectopic Pregnancy Risk

    The underlying mechanism for an ectopic pregnancy (EP) following an intrauterine embryo transfer is not fully understood. While ectopic pregnancies result from alterations in the tubal environment in most natural cycles, endometrial receptivity is the primary concern following in vitro fertilization (IVF). Elevations in estradiol and progesterone levels during controlled ovarian stimulation (COS) are associated with morphological changes in the endometrium that may augment or interfere with…

    The underlying mechanism for an ectopic pregnancy (EP) following an intrauterine embryo transfer is not fully understood. While ectopic pregnancies result from alterations in the tubal environment in most natural cycles, endometrial receptivity is the primary concern following in vitro fertilization (IVF). Elevations in estradiol and progesterone levels during controlled ovarian stimulation (COS) are associated with morphological changes in the endometrium that may augment or interfere with normal implantation. Perhaps as a result of the exaggerated hormonal environment resulting from IVF stimulation, the risk of EP has been shown to be greater during a fresh compared to frozen embryo transfer (ET) cycle. However, despite lower steroid hormone levels in a frozen ET cycle, ectopic risk is still higher than in natural cycles. This study aimed to determine whether estradiol (E2) and progesterone (P4) levels during a frozen, blastocyst ET cycles are associated with EP risk.

    See publication
  • The Likelihood of Implantation Following Transfer of a Euploid Embryo is not Correlated with Self-Reported Race

    Data are conflicting regarding the impact of a patient’s race on assisted reproductive technology treatment success. A study published by Dhillon et al. observed lower IVF pregnancy rates in African American (AA) and Asian women as compared to Caucasian women; however, these findings were limited to cycles involving transfer of fresh, unscreened embryos. The current study sought to determine differences in pregnancy outcomes in women of different racial groups who undergo a single, euploid…

    Data are conflicting regarding the impact of a patient’s race on assisted reproductive technology treatment success. A study published by Dhillon et al. observed lower IVF pregnancy rates in African American (AA) and Asian women as compared to Caucasian women; however, these findings were limited to cycles involving transfer of fresh, unscreened embryos. The current study sought to determine differences in pregnancy outcomes in women of different racial groups who undergo a single, euploid frozen embryo transfer (FET).

    See publication
  • Caring for BRCA Carriers: Strategies to Promote Health and Preserve Fertilty

    Journal of Women's Health and Gynecology

    BRCA1 and BRCA2 mutation carriers are at increased risk for breast and ovarian cancer, with lifetime risks approximately 49-72% for breast cancer and 17-59% for ovarian cancer. The National Cancer comprehensive Network recommends routine screening as well as a risk-reducing surgery to remove the fallopian tubes and ovaries for BRCA carriers between ages 35 to 40 or after the completion of childbearing. Since many women have not completed childbearing by age 40, they have the option of…

    BRCA1 and BRCA2 mutation carriers are at increased risk for breast and ovarian cancer, with lifetime risks approximately 49-72% for breast cancer and 17-59% for ovarian cancer. The National Cancer comprehensive Network recommends routine screening as well as a risk-reducing surgery to remove the fallopian tubes and ovaries for BRCA carriers between ages 35 to 40 or after the completion of childbearing. Since many women have not completed childbearing by age 40, they have the option of undergoing fertility preservation prior to undergoing this risk-reducing surgery. Additionally, use of Preimplantation Genetic Diagnosis (PGD) allows couples to prevent transmission to their offspring. BRCA carriers may be at greater risk for diminished ovarian reserve, yet studies regarding the effect of BRCA carrier status on fertility remain inconsistent in their conclusions. To date, researchers have demonstrated that infertility treatment is safe in BRCA carriers. BRCA carriers are faced with complex challenges and will benefit from consultation with a fertility specialist to discuss options for fertility preservation to safely build the family they desire.

    See publication
  • Blastocyst vitrification, cryostorage and warming does not affect live birth rate, infant birth weight or timing of delivery

    Reproductive Biomedicine Online

    Does vitrification and warming affect live birth rate, infant birth weight and timing of delivery?

    See publication
  • The cumulative dose of ganadotropins used for controlled ovarian stimulation does not influence the odds of embryonic aneuploidy in patients with normal ovarian response

    Journal of Assisted Reproductive Genetics

    Controlled ovarian hyperstimulation (COH) promotes multifollicular growth, increasing the chance of
    obtaining euploid embryos that will successfully implant. Whether aneuploidy is increased from COH with exogenous gonadotropins interfering with natural selection of dominant follicles is a concern. This study evaluates the association between gonadotropin exposure and aneuploidy.

    See publication

Honors & Awards

  • New York Rising Star

    Super Doctors Organization

  • 2nd Place Prize Research Paper

    Pacific Coast Reproductive Society

  • Fellow in Training Research Award / Scholarship

    Pacific Coast Reproductive Society

  • Fellow Research Award

    New York Obstetrical Society

    Fellow Research Award for oral presentation of abstract entitled 'Using old technology to ask a new question: does the uterus age?'

  • Fellow in Training Research Award / Scholarship

    Pacific Coast Reproductive Society

Organizations

  • American Society for Reproductive Medicine

    Member

    - Present

    The American Society for Reproductive Medicine (ASRM) is a multidisciplinary organization dedicated to the advancement of the science and practice of reproductive medicine. It provides a forum for lay public, researchers, physicians and affiliated health workers through education, publications, and meetings.

  • American Society for Reproductive Medicine Task Force

    -

    -

More activity by Lucky

View Lucky’s full profile

  • See who you know in common
  • Get introduced
  • Contact Lucky directly
Join to view full profile

Other similar profiles

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Add new skills with these courses